A new uPAR-targeting fluorescent probe for optical guided intracranial surgery in resection of a meningioma-a case report.
Acta Neurochir (Wien)
; 164(1): 267-271, 2022 01.
Article
en En
| MEDLINE
| ID: mdl-34748074
Meningiomas are benign lesion although anot insignificant number experiences recurrences despite Simpson grade 1 removal. FG001 is a compound with a fluorophore (ICG) that binds to a urokinase-type plasminogen activator receptor (uPAR) and is currently investigated at our institution in a first-in-human trial. The patient presented with a plausible malignant glioma but proved to be a grade 1 meningioma. FG001 could delineated the tumor not only on the surface but supplementary in the cavity to remove safely the dural attachment. We present FG001 as a new promising tool for improved surgical radicality beyond the intended indication, provided that a prospective validation in a consecutive meningioma cohort demonstrates similar results.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Glioma
/
Neoplasias Meníngeas
/
Meningioma
Límite:
Child
/
Humans
Idioma:
En
Revista:
Acta Neurochir (Wien)
Año:
2022
Tipo del documento:
Article
País de afiliación:
Dinamarca
Pais de publicación:
Austria